Status not kept up to date
Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients
NCT03005756 · Asan Medical Center · Updated 10 Sept 2018
- What is being tested
- Needle guiding robot
- For
- Carcinoma, Hepatocellular
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years to 80 years. About 20 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 25 Jan 2017, ends March 2019. Registered 29 Dec 2016.
- Results
- None posted yet.
In the researchers' words
The needle guiding robot helps targeting of radiofrequency ablation needles by matching computed tomography images and patients' bodies. Actual insertion of needles will be performed by doctors. This study evaluates the safety and efficacy of needle targeting on patients with hepatocellular carcinoma.
Sites
- Asan Medical CenterSeoul, South Korea